Cannabinoid Safety and Regulation Act
Sponsored By: Senator Sen. Wyden, Ron [D-OR]
Introduced
Summary
This bill would establish an FDA-led federal regulatory framework for hemp-derived cannabinoid products that sets testing, labeling, packaging, age limits, facility registration, and enforcement rules. It would also fund research and prevention programs for impaired driving and underage use.
Show full summary
- Families and young people: Sets a 21+ sales limit for remote purchases, requires reliable age verification, and bans packaging designed to appeal to children.
- Consumers and pet owners: Requires clear labels showing total THC and other cannabinoids per serving, species warnings for animal products, accredited lab testing, safety thresholds, and terpene limits (added terpenes ≤5%, natural terpenes ≤6%).
- Manufacturers, labs, and states: Requires facility registration, current good manufacturing practices, ISO 17025 or equivalent lab accreditation, product listing, and exposes violators to civil fines up to $15,000 per violation and up to $15 million per proceeding.
*This bill would increase federal spending by authorizing $30 million per year for 2026–2030 for impaired-driving research and education and $25 million per year for 2026–2030 for underage-use prevention grants.*
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
6 provisions identified: 4 benefits, 1 costs, 1 mixed.
New national safety and label rules
This bill would require the Secretary to set national product safety and label rules within one year. In States without serving-size laws, THC would be capped at 5 mg per serving and 50 mg per container for edibles, inhalables, and topicals, and 10 mg per container for drinkable products. Labels would need a standard information panel, a universal cannabinoid symbol, and safety-test-result information within 90 days after the agency issues a rule or order. States could not require different labels for products covered by this chapter.
Safer packaging, flavors, and age checks
This bill would ban many added flavors in electronic vaping products and limit terpene levels to 5–6% of product weight. It would bar products and packaging that imitate candy or appeal to children, and require gummy products to be simple geometric shapes. Remote sellers of THC-containing products would have to verify buyers are 21 using a reliable online age check or a valid government photo ID, including Tribal IDs.
More funding for cannabis health research
This bill would raise baseline public-health surveillance funding to $596 million per year for FY2026–2030. It would add $100 million per year for cannabis adverse-effect surveillance for the same years. The bill would also fund grants to prevent underage cannabis use, providing $25 million per year for FY2026–2030 and prioritizing underserved and highly affected communities.
Stricter manufacturing and lab rules
This bill would require good manufacturing practice rules within nine months and testing regulations within 18 months. Labs that test cannabinoid products would need state certification or accreditation and ISO 17025-level proof, and must use validated, published methods for potency and contaminant testing. The Secretary and the DEA Administrator would enter an MOU on accreditation within 90 days. These steps would improve product safety but would also raise compliance and accreditation costs for manufacturers and testing labs.
Funding to reduce cannabis-impaired driving
This bill would direct DOT and NHTSA to develop best practices, national campaigns, and a National Roadside Survey to reduce cannabis-impaired driving. States could get grant money for enforcement, toxicology lab capacity, and education. Congress would appropriate $40 million per year for the State grant program and $30 million per year for DOT impaired-driving research and campaigns for FY2026–2030.
New facility registration, fees, and suspensions
This bill would require companies that make, package, import, label, or hold cannabinoid products to register each facility and list products. Existing facilities would register within 90 days and new facilities within 30 days of starting covered activities. The Secretary could charge a registration fee (up to $500 in FY2026, then adjusted by CPI) and require renewal every even-numbered year. The Secretary could suspend registrations for products that have a reasonable probability of serious harm and require quick corrective-action plans.
Free Policy Watch
You just read the policy. Now see what it costs you.
Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.
Pick a topic to get started
Sponsors & CoSponsors
Sponsor
Sen. Wyden, Ron [D-OR]
OR • D
Cosponsors
Sen. Merkley, Jeff [D-OR]
OR • D
Sponsored 12/15/2025
Sen. Smith, Tina [D-MN]
MN • D
Sponsored 1/13/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in